Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yingying Lin, Xiaofan Lai, Tianxiang Lei, Yuan Qiu, Qiwen Deng, Qi Liu, Zhongxing Wang & Wenqi Huang. (2023) Neutrophil-Related Gene Expression Signatures in Idiopathic Pulmonary Fibrosis: Implications for Disease Characteristic and Identification of Diagnostic Hub Genes. Journal of Inflammation Research 16, pages 2503-2519.
Read now
Read now
Articles from other publishers (21)
Yanli Yang, Yu Chen, Yang Liu, Zongdi Ning, Zhaoliang Zhang, Yan Zhang, Ke Xu & Liyun Zhang. (2023) Mesenchymal stem cells and pulmonary fibrosis: a bibliometric and visualization analysis of literature published between 2002 and 2021. Frontiers in Pharmacology 14.
Crossref
Crossref
Elisabeth Fließer, Thomas Lins, Johannes Lorenz Berg, Martin Kolb & Grazyna Kwapiszewska. (2023) The endothelium in lung fibrosis: a core signaling hub in disease pathogenesis?. American Journal of Physiology-Cell Physiology 325:1, pages C2-C16.
Crossref
Crossref
Nikitha Naomi Dsouza, Varun Alampady, Krishnaprasad Baby, Swastika Maity, Bharath Harohalli Byregowda & Yogendra Nayak. (2023) Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis. Inflammopharmacology 31:3, pages 1167-1182.
Crossref
Crossref
Shan Wang, Wei Rao, Ashley Hoffman, Jennifer Lin, Justin Li, Tao LinAudrey-Ann LiewMatthew Vincent, Tinne C. J. MertensHarry Karmouty-Quintana, Christopher P. Crum, Mark L. Metersky, David A. Schwartz, Peter J. A. Davies, Clifford Stephan, Soma S. K. Jyothula, Ajay Sheshadri, Erik Eddie SuarezHoward J. Huang, John F. Engelhardt, Burton F. Dickey, Kalpaj R. ParekhFrank D. McKeon & Wa Xian. (2023) Cloning a profibrotic stem cell variant in idiopathic pulmonary fibrosis. Science Translational Medicine 15:693.
Crossref
Crossref
Elisabetta Cocconcelli, Nicol Bernardinello, Chiara Giraudo, Gioele Castelli, Clorinda Greco, Roberta Polverosi, Marina Saetta, Paolo Spagnolo & Elisabetta Balestro. (2022) Radiological Assessment in Idiopathic Pulmonary Fibrosis (IPF) Patients According to MUC5B Polymorphism. International Journal of Molecular Sciences 23:24, pages 15890.
Crossref
Crossref
Sanja Stankovic, Mihailo Stjepanovic & Milika Asanin. 2022. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis.
Marlies Wijsenbeek, Atsushi Suzuki & Toby M Maher. (2022) Interstitial lung diseases. The Lancet 400:10354, pages 769-786.
Crossref
Crossref
Ian T. Stancil, Jacob E. Michalski & David A. Schwartz. (2022) An Airway-Centric View of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 206:4, pages 410-416.
Crossref
Crossref
Joanna Y. Wang & Lisa R. Young. (2022) Insights into the Pathogenesis of Pulmonary Fibrosis from Genetic Diseases. American Journal of Respiratory Cell and Molecular Biology 67:1, pages 20-35.
Crossref
Crossref
Weifeng Tang, Min Li, Xiaoting Yangzhong, Xifeng Zhang, Anju Zu, Yunjiao Hou, Lin Li & Shibo Sun. (2022) Hippo signaling pathway and respiratory diseases. Cell Death Discovery 8:1.
Crossref
Crossref
Ashesh Chakraborty, Michal Mastalerz, Meshal Ansari, Herbert B. Schiller & Claudia A. Staab-Weijnitz. (2022) Emerging Roles of Airway Epithelial Cells in Idiopathic Pulmonary Fibrosis. Cells 11:6, pages 1050.
Crossref
Crossref
Jacob E. Michalski, Jonathan S. Kurche & David A. Schwartz. (2022) From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?. Translational Research 241, pages 13-24.
Crossref
Crossref
Benjamin J. MossStefan W. RyterIvan O. Rosas. (2022) Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis. Annual Review of Pathology: Mechanisms of Disease 17:1, pages 515-546.
Crossref
Crossref
Tanjila Khan, Ricardo J. Jose, Elisabetta A. Renzoni & Maria Mouyis. (2021) A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Bronchiectasis. Rheumatology and Therapy 8:4, pages 1463-1475.
Crossref
Crossref
Kexiong Zhang, Lu Xu & Yu-Sheng Cong. (2021) Telomere Dysfunction in Idiopathic Pulmonary Fibrosis. Frontiers in Medicine 8.
Crossref
Crossref
Chiara Giacomelli, Rebecca Piccarducci, Laura Marchetti, Chiara Romei & Claudia Martini. (2021) Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients. Biochemical Pharmacology 193, pages 114812.
Crossref
Crossref
Martina Sterclova, Amit Kishore, Katerina Sikorova, Jelena Skibova, Martin Petrek, Martina Vasakova & Martina Vasakova. (2021) Effect of genotype on the disease course in idiopathic pulmonary fibrosis despite antifibrotic treatment. Biomedical Reports 15:5.
Crossref
Crossref
Ian T. Stancil, Jacob E. Michalski, Duncan Davis-Hall, Hong Wei Chu, Jin-Ah Park, Chelsea M. Magin, Ivana V. Yang, Bradford J. Smith, Evgenia Dobrinskikh & David A. Schwartz. (2021) Pulmonary fibrosis distal airway epithelia are dynamically and structurally dysfunctional. Nature Communications 12:1.
Crossref
Crossref
Anna Valeria Samarelli, Roberto Tonelli, Irene Heijink, Aina Martin Medina, Alessandro Marchioni, Giulia Bruzzi, Ivana Castaniere, Dario Andrisani, Filippo Gozzi, Linda Manicardi, Antonio Moretti, Stefania Cerri, Riccardo Fantini, Luca Tabbì, Chiara Nani, Ilenia Mastrolia, Daniel J. Weiss, Massimo Dominici & Enrico Clini. (2021) Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution. Frontiers in Pharmacology 12.
Crossref
Crossref
Fabrizio Luppi, Meena Kalluri, Paola Faverio, Michael Kreuter & Giovanni Ferrara. (2021) Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management. Respiratory Research 22:1.
Crossref
Crossref
Fabrizio Luppi, Meena Kalluri, Paola Faverio, Michael Kreuter & Giovanni Ferrara. (2021) Die idiopathische pulmonale Fibrose jenseits der Lunge: Krankheitsmechanismen verstehen, um Diagnose und Therapie zu verbessern. Kompass Pneumologie 9:5, pages 230-243.
Crossref
Crossref